Asset Details
Do you wish to reserve the book?
Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus
Do you wish to request the book?
Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus
2022
Overview
Purpose of ReviewHepatitis B virus (HBV) can be a potentially life-threatening liver infection. Prior to starting therapy, the first step is to establish the diagnosis, then to assess disease severity and determine if treatment is indicated. Assessing the degree of liver fibrosis is imperative to guiding treatment options. While liver biopsy has been the primary method to establish the degree of fibrosis, noninvasive tests (NIT) have now replaced liver biopsy as the initial step.Recent FindingsHere, we present a recent review of literature on NIT to assess liver fibrosis in chronic HBV from 2019 to 2022.SummaryBeing able to use NIT (blood- and/or imaging-based) to assess fibrosis and help guide treatment can help impact and lower disease burden as well as life-threatening complications of liver disease.
